Drug intelligence / Profile preview

(4-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-methoxy-3-oxopropyl}phenyl)methaneseleninic acid

Development stage
Unknown
Lead developer
ZY Therapeutics
Modality
Small Molecules
Administration
Unknown; No Clinical Data Available.
01

Overview

(4 {(2S)-2 [(tert butoxycarbonyl amino methoxy oxopropyl phenyl methaneseleninic acid is a small molecule organic compound derived from phenylalanine. It features a seleninic acid group attached to the para position of the phenyl ring and is protected by a tert-butoxycarbonyl (Boc) group on the amino terminus. The compound is primarily used in research and has not been developed as a therapeutic agent for any specific disease. Its mechanism of action is not established in clinical or preclinical studies, and it does not have any approved indications or ongoing clinical trials.[1][5][10]

Other names
(4-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-methoxy-3-oxopropyl}phenyl)methaneseleninic acid{4-[(2S)-3-Methoxy-2-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-oxopropyl]phenyl}methaneseleninic acid[1][5]L-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-4-[(hydroxyseleninyl)methyl]-, methyl ester[1]Acide {4-[(2S)-3-méthoxy-2-({[(2-méthylpropanyl)oxy]carbonyl}amino)-3-oxopropyl]phényl}méthaneséléninique (French)[1]

Beyond the preview

Go deeper on (4-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-methoxy-3-oxopropyl}phenyl)methaneseleninic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (4-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-methoxy-3-oxopropyl}phenyl)methaneseleninic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call